It was reported that during a cryo ablation procedure, after the sheath was place in the left atrium (la), and the dilator removed and aspirated, the physician observed st segment elevation in two of the leads.It was also reported that air was seen in the sheath handle.The sheath was pulled back into right atrium (ra) and an increase in the st segment elevation increased.After some time the st segment elevations "vanished." it was then reported that after a transseptal device was used, the patient had an air embolism.The case was aborted.No further patient complications have been reported as a result of this event.
|
Product event summary: the 4fc12 sheath with lot number 0011375168 was returned and analyzed.Visual inspection before functional testing and dissection was performed on the shaft, handle, and dilator.No anomaly was identified during the external visual inspection.All the handle, shaft and sideport were intact with no apparent issue.The performance test with sentinel blackbelt leak tester was performed.All performance tests were in the acceptable range.The shaft, side tube, and valve were all leak-tight with no apparent issue.In conclusion, the reported clinical issues, embolism and st elevation, occurred during the procedure.There is no indication of a relationship of the adverse event to the performance or a malfunction of the product.The physical product was not returned for analysis.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|